Introduction
The genus Xanthium (Asteraceae, Heliantheae), represented by 25 species, exhibits a global distribution and is found abundantly throughout Eurasia and America. This genus has been the subject of many chemical studies, which have led to the isolation of a special type of sesquiterpene lactones (xanthanolides) (Saxena and Mondal, 1994) , diterpenes (Piacente et al., 1996) , thiazinediones (Ma et al., 1998; Qin et al., 2006) , sterols and caffeoylquinic acids (Agata et al., 1993) as main secondary metabolites. Xanthium species have been used in traditional herbal medicine worldwide; some of them have been applied for the treatment of basal cell carcinoma, different cancers and "cold tumours" (Hartwell, 1968) . X. italicum Moretti [syn. X. strumarium L. subsp. italicum (Moretti) D. Löve], a member of the X. strumarium group, has been used in folk medicine against cancers in Latin-America (Hartwell, 1968) . Previous investigations revealed the presence of xanthanolides and phytosterols in X. italicum (Marco et al., 1993; Tsankova et al., 1993 Tsankova et al., , 1994 .
In the course of our screening programme for antiproliferative compounds in Central and Eastern European Asteraceae species, extracts of X. italicum were investigated earlier (Réthy et al., 2007) . High tumour cell growth inhibitory activities on HeLa (cervix adenocarcinoma), A431 (skin carcinoma), and MCF7 (breast adenocarcinoma) human cell lines were recorded in vitro for different lipophilic extracts by means of the MTT assay. The present paper reports on investigations of the antiproliferative effects of the extracts of different plant parts of X. italicum, collected before and in the fl owering stage, with the aim of selecting the most effective extract. The bioassay-guided fractionation of the CHCl 3 extract of the leaves was additionally performed in an effort to identify the compounds responsible for the tumour cell growth inhibitory effect. This led to the isolation and identifi cation of four xanthanolides: xanthatin (1), 4-epixanthanol (2), 4-epi-isoxanthanol (3), and 2-hydroxyxanthinosin (4), all possessing tumour cell growth inhibitory activities.
Results and Discussion
The dried and powdered plant parts (radix, fl ower, stem and leaf) collected before and during the fl owering period were extracted with MeOH and, after evaporation, the residues from the extracts were subjected to solvent-solvent partitioning. Extraction with lipophilic solvents yielded nhexane-, CHCl 3 -and H 2 O-soluble phases. These fractions, together with the original MeOH extract, were tested for their tumour cell prolifera- tion inhibitory activities on the HeLa, A431 and MCF7 cell lines (Fig. 1) . It was observed that the main active components proved to be accumulated in the leaves and fl owers, especially in the n-hexane and CHCl 3 extracts. The extracts from the stems exerted only low effects (< 53%) on all three cell lines. The extracts from the roots in the fl owering stage were more active than those from 
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Inhibition of proliferation (%) before the fl owering period. The fractions with different polarities revealed that the CHCl 3 extracts exerted the highest activity, with exception of the root during the fl owering period, where the active compounds accumulated in the n-hexane extracts.
The CHCl 3 extract of the leaves exhibited marked cell growth inhibitory activities of 102.0, 88.5 and 99.1% on the HeLa, MCF7 and A431 cells, respectively, and this extract was therefore selected for a detailed study. In order to identify the active components, the CHCl 3 extract was fi rst separated by column chromatography into fi ve main fractions. Of these fractions I and IV (at 10 μg/ml) exhibited cell growth inhibitory activities of 85.0 and 97.2% on the HeLa, 101.2 and 88.2% on the A431, and 93.2 and 86.3% on the MCF7 cell line. Fraction I was subjected to multiple chromatographic purifications, including vacuum liquid chromatography (VLC), centrifugal planar chromatography (CPC) and HPLC, which afforded compounds 1 -4. Compound 1 was obtained as white crystals, and identifi ed as xanthatin by comparison of its 13 C NMR spectral data with those published by Marco et al. (1993) . The detailed NMR studies, including 1 H NMR, JMOD, 1 H-1 H COSY, NOESY, HSQC and HMBC experiments, resulted in complete 1 H chemical shift assignments for 1, as listed in the experimental section. The NOESY experiment provided information on the stereochemistry of the chiral centres (C-7, C-8 and C-10). The Overhauser effects detected between H-8/H-14, H-8/H-6β and H-9β/H-8, and between H-6α/H-7 and H-7/H-9α proved the trans lactone ring junction and the β-oriented 14-methyl group. Xanthatin (1), Fig. 2 , which was obtained in the highest yield, is one of the main xanthanolides: it has been isolated previously from X. italicum (Tsankova et al., 1994) , X. macrocarpum (Lavault et al., 2005) , X. spinosum (Omar et al., 1984) , X. sibiricum (Sato et al., 1997) , and X. strumarium (McMillan et al., 1975) . This compound has attracted considerable attention because of its antileishmanial, antifungal (Lavault et al., 2005) , and nitric oxide synthesis and COX-2 inhibitory activities (Yoon et al., 2008) .
Compounds 2 and 3 were isolated as colourless oils. On the basis of their 1 H and 13 C NMR data, they were identifi ed as 4-epixanthanol (2) and 4-epi-isoxanthanol (3) (Marco et al., 1993) (Fig. 2) .
Compound 4 was isolated as a colourless gum. Its 1 H NMR and JMOD spectra (Table I) (Fig. 3) . All of the above data supported the structure of 2-hydroxyxanthinosin for 4 (Fig. 2) , with the fi rst stereochemical characterization of C-2, and determination of the complete 13 C NMR assignments as listed in Table I .
The isolated xanthanolides were tested against the HeLa, MCF7 and A431 cell lines, and all were found to exert signifi cant cell growth inhibitory effects (Table II) . Compound 1 demonstrated the highest activity with IC 50 values of 8.00, 3.44 and 5.19 µM on the HeLa, A431 and MCF7 cell lines, respectively; its potency was close to that of the positive control, cisplatin. 2-Hydroxyxanthinosin (4) displayed signifi cant activity (IC 50 7.78 µM) against HeLa cells, and 2 and 3 exerted moderate effects (IC 50 15.53−37.62 µM) against all three tumour cell lines.
Compounds 1 -4 contain an α-methylene-γ-lactone ring, which is generally regarded as a structural requirement of sesquiterpenes for cytotoxic activity. The most potent, xanthatin (1), has an additional α,β-unsaturated carbonyl group in the side chain; this structural feature presumably enhances the antitumour activity. In previous pharmacological studies, this side chain was similarly found to be responsible for pronounced (Yoon et al., 2008) .
In conclusion, the strong inhibitory effect of the leaves of X. italicum on the proliferation of cultured human tumour cell lines (HeLa, MCF7 and A431) may be attributed to xanthanolides. Predominantly the content of the most active main compound, xanthatin (1), determines the anti tumour activity of the extracts, with the minor xanthanolides playing additional roles in this effect.
Material and Methods

General experimental procedures
The melting point is uncorrected. NMR spectra were recorded in CDCl 3 on a Bruker Avance DRX 500 spectrometer (500 MHz for H COSY, HSQC, HMBC and NOESY) were set up, performed and processed with the standard Bruker protocol. For VLC, silica gel (Kieselgel GF 254 , 15 μm, Merck) was used. Preparative TLC was carried out on silica gel (Kieselgel 60F 254 , Merck). The chromatograms were visualized under UV light at 254 nm, and by spraying with concentrated vanillin/sulfuric acid, followed by heating at 110 °C for 10 min. CPC was carried out on a Chromatotron (Harrison Research Inc., Palo Alto, CA, USA) apparatus, using manually coated silica gel (60 GF 254 , Merck) plates with 2 or 4 mm thickness. For column chromatography, polyamide (ICN Polyamide 6, Germany, mean particle size 50 − 160 µm) was used. RP-HPLC was carried out on a LiChrospher 100 RP-18 (10 µm, 250 × 4 mm) reversed-phase (RP) column (Merck), and NP-HPLC on LiChrospher Si 100 (5 µm, 250 × 4 mm), using a Waters instrument: Pump 600E, Dual λ Absorbance Detector 2487, Injector Rheodyne 7725i, with detection at 254 and 280 nm.
Plant material
Plant materials were collected in August 2006 in Budaörs and in September 2006 on the banks of the River Tisza in Szentes, Hungary, and identifi ed by Dr. Anikó Böszörményi (Department of Plant Biology, University of Szeged, Hungary). Voucher specimens (765 and 766) are deposited in the herbarium of the Department of Pharmacognosy, University of Szeged, Hungary. The plant materials were dried at room temperature, yielding 1070 g of aerial parts and 310 g of roots from the fi rst gathering, and 1020 g of leaves, 680 g of roots, 150 g of fl owers and 870 g of stems from the second gathering.
Preparation of the extract for antiproliferative screening
10 g of the dried and powdered plant parts (radix, fl ower, leaves, and stem) were extracted with 3 × 100 ml MeOH. The extracts were concentrated in vacuo, and then subjected to liquid-liquid partition with n-hexane (3 × 50 ml) and CHCl 3 (3 × 50 ml). The fractions were concentrated and tested for antiproliferative activity.
Isolation of the compounds
The dried leaves (1010 g) of the plant were crushed and percolated with 10 l MeOH at room temperature. The MeOH extract was concentrated to 500 ml; then 500 ml H 2 O were added. The extract was subjected to solvent-solvent partition using 5 × 1000 ml n-hexane and 5 × 1000 ml CHCl 3 . The CHCl 3 fraction (31.32 g) was chromatographed on a polyamide column with mixtures of MeOH/H 2 O (1:4, 2:3, 3:2, and 4:1). A total of 50 fractions were collected and combined on the basis of TLC monitoring, affording 5 main fractions (I-V). Sesquiterpenes were detected in fraction I. Upon standing, fraction I afforded a considerable amount of a crystalline material, which was recrystallized from MeOH to yield compound 1 (1.12 g). The mother liquor that remained (10.22 g) was subjected to VLC on silica gel, using a gradient system of n-hexane/acetone (9:1, 4:1, 7:3, and 1:1, 100 ml each) and CHCl 3 /MeOH (9:1, 7:3, and 1:1, 100 ml each). This separation resulted in 11 sub-fractions, I/1 − I/11, which were tested on the HeLa, MCF7 and A431 cell lines. Fractions I/4 and I/5 exhibited signifi cant activity, and were further purifi ed. Fraction I/4 (3.39 g), obtained with n-hexane/acetone (7:3), was subjected repeatedly to silica gel VLC, using toluene/EtOAc mixtures of increasing polarity. From fraction I/4.1, 60.3 mg of 2 was crystallized. The remaining part of this fraction was fractionated fi rst by CPC, using a gradient system of toluene/EtOAc (9:1, 4:1, 7:3, 3:2, and 1:1), and then purifi ed by NP-HPLC, using cyclohexane/EtOAc/EtOH (20:10:1) as mobile phase (fl ow rate 1 ml/min), affording 3 (42 mg). Fraction I/5 (1.7 g), obtained with n-hexane/acetone (1:1), was further purifi ed by RPC on silica gel, using a gradient system of toluene/EtOAc. Selected fractions from this chromatography were subjected to RP-HPLC, using MeOH/H 2 O (3:2) (fl ow rate 1 ml/min), to yield compound 4 (10.8 mg) (t R = 3.36 min). Marco et al. (1993) . Table I .
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Bioassays
Cytotoxic effects were measured in vitro on the HeLa (human cervix adenocarcinoma), A431 (skin carcinoma), and MCF7 (breast adenocarcinoma) cell lines, using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] colorimetric assay. A limited amount of human cancer cells (5000/well) were seeded onto a 96-well microplate, and allowed to adhere overnight before the drugs were introduced. The original medium was then removed, 200 μl culture medium containing the compound of interest were added, and the cells were incubated for 72 h. The tested extracts and compounds were dissolved in DMSO. The fi nal content of DMSO never exceeded 0.3%, and therefore had no essential effect on the cell growth. Next the living cells were assayed: aliquots (20 μl at 5 mg/ml) of the MTT stock solution were pipetted into each well and reduced by viable cells to an insoluble formazan product during a further 4 h. After this contact period, the medium was removed, and the formazan crystals were dissolved in 100 μl DMSO by gentle shaking for 60 min. Finally, the absorbance was measured at 545 nm with a microplate reader (Mosmann, 1983) . In this way, the cell growth or drug toxicity was determined. The 50% inhibitory concentration (IC 50 ) was derived from the concentration-response curves fi tted to the measured points by GraphPad Prism 2.01. All in vitro experiments were carried out on 2 microplates with at least 5 parallel wells. Cisplatin and doxorubicin were used as positive controls.
